CinDome Pharma, LLC Report issue

For profit Phase 2
Founded: Wilmington DE United States (2016)

Organization Overview

First Clinical Trial
2019
NCT04026997
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

CinDome Pharma, Inc. | CinDome Pharma, LLC